Horizon Pharma, Inc.

NASDAQ: HZNP
$48.12
+$0.54 (+1.1%)
Closing price June 5, 2020
Horizon Pharma shares exploded on Thursday after the firm announced results from its late-stage trial evaluating teprotumumab for the treatment of active thyroid eye disease.
Chris Lange
The top analyst upgrades, downgrades and other research calls from Wednesday included Altice, Blue Apron, CubeSmart, Horizon Pharma, KB Home, Las Vegas Sands, Mylan and Switch.
Lee Jackson
The top analyst upgrades, downgrades and other research calls from Monday include Applied Materials, Barrick Gold, Comcast, GoDaddy, Intel, PG&E, Qualcomm and Sirius XM.
Jon C. Ogg
Here are 10 top Ireland-based public companies with shares that are traded in the United States that may be worth putting on a watchlist.
Trey Thoelcke
These five top companies with different health care businesses all can provide nice exposure to the sector in growth portfolios. All are rated Buy at Jefferies and make sense now.
Lee Jackson
24/7 Wall St. screened the Stifel specialty pharmaceutical list and found five stock rated Buy that have massive upside potential and probably don’t have the investment risk of some of the more...
Lee Jackson
The top analyst upgrades, downgrades and other research calls include Archer Daniels Midland, BlackRock, DexCom, Mallinckrodt, McDonald's, Philip Morris and Redfin.
Jon C. Ogg
Horizon Pharma released a better than expected quarterly earnings report before the markets opened on Monday.
Chris Lange
The analysts at Stifel have focused on biotech and specialty pharma companies that not only have data that could prove to be huge, but they are offering aggressive accounts the best entry points in...
Lee Jackson
Pandora, Hertz, Horizon Pharma, and Chicago Bridge & Iron all posted new 52-week lows on Tuesday.
Paul Ausick
Horizon Pharma, TherapeuticsMD, DDR Corp., and Cobalt Energy all posted new 52-week lows on Monday.
Paul Ausick
Horizon Pharma PLC (NASDAQ: HZNP) saw its shares hit a 52-week low on Monday after the company released its first-quarter financial results. The company said that it had $0.21 in EPS and $220.9...
Chris Lange
The S&P 500 and Dow are pushing new highs as 2016 comes to a close. While the post-election tailwind has been incredibly strong, there are still companies holding back this rally.
Chris Lange
Horizon Pharma PLC saw its shares take a big step back on Thursday after the company reported topline results from one of its late-stage trials.
Chris Lange
Horizon Pharma PLC (NASDAQ: HZNP) reported its third-quarter financial results on Monday before the markets opened. The company said that it had $0.70 in earnings per share (EPS) and $208.7 million...
Chris Lange